US2007059732A1PendingUtilityA1

Detection of target analytes using particles and electrodes

Assignee: CLINICAL MICRO SENSORS INCPriority: Oct 27, 1998Filed: Jun 1, 2006Published: Mar 15, 2007
Est. expiryOct 27, 2018(expired)· nominal 20-yr term from priority
B01J 13/00G01N 27/3275Y10T436/143333B82Y 30/00Y10S977/92G01N 27/3277C12Q 1/6825B82Y 15/00Y10S977/773G01N 27/48
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.

Claims

exact text as granted — not AI-modified
1 - 6 . (canceled)  
     
     
         7 . A method of detecting cells using colloid particles, comprising: 
 a) forming an assay complex on a surface, wherein said assay complex comprises 
 1) said cells;  
 2) at least one colloid particle comprising a binding ligand; and  
 3) at least one signaling moiety that is either directly or indirectly attached to said assay complex; and  
   b) detecting said cells by detecting said signaling moiety.    
     
     
         8 . A method according to  claim 7 , wherein said surface is an electrode.  
     
     
         9 . A method according to  claim 7 , wherein said colloid particle is a gold colloid particle.  
     
     
         10 . A method according to  claim 7 , wherein said colloid particle further comprises a self-assembled monolayer (SAM).  
     
     
         11 . A method according to  claim 10 , wherein said SAM is a mixed SAM comprising a at least two species of molecules.  
     
     
         12 . A method according to  claim 10 , wherein said binding ligand is attached to said SAM via a transitional metal ligand.  
     
     
         13 . A method according to  claim 12 , wherein said transitional metal ligand comprises nickel.  
     
     
         14 . A method according to any of  claims 7  to  13 , wherein said binding ligand is a protein.  
     
     
         15 . A method according to  claim 7 , wherein said signaling moiety is an electron transfer moiety (ETM).  
     
     
         16 . A method according to  claim 7 , wherein said signaling moiety is a fluorescent moiety.  
     
     
         17 . A composition comprising a colloid particle comprising: 
 1) at least one signaling moiety; and    2) a mixed self-assembled monolayer (SAM), wherein said SAM comprises at least two species of molecules.    
     
     
         18 . A composition according to  claim 17 , wherein one of said species of molecules comprises a protein.  
     
     
         19 . A composition according to  claim 17 , wherein one of said species of molecule comprises an insulator.  
     
     
         20 . A composition according to  claim 19 , wherein said insulator comprises an alkyl or a heteroalkyl oligomer.  
     
     
         21 . A composition according to  claim 17 , wherein said signaling moiety comprises an electron transfer moiety (ETM).  
     
     
         22 . A composition comprising a colloid particle comprising: 
 a) a self-assembled monolayer (SAM); and    b) a non-DNA binding ligand attached to said colloid particle.    
     
     
         23 . A composition according to  claim 22 , wherein said binding ligand comprises a protein.  
     
     
         24 . A composition according to  claim 23 , wherein said protein is a peptide.

Join the waitlist — get patent alerts

Track US2007059732A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.